During the pandemic, some doctors anecdotally began noticing that some people with cancer who got very sick with COVID-19 saw their tumors shrink or grow more slowly…
Typically, monocytes, as part of the immune system, cruise the bloodstream and alert other immune cells to the presence of foreign cells or pathogens; some monocytes can attract cancer-killing immune cells to tumors, but others aren’t as effective in doing so. That’s because in some cases, cancer cells can co-opt monocytes —“like a demon summoning forces” —and form an immune wall protecting the tumor from being discovered and attacked by additional immune defenses.But during a COVID-19 infection, SARS-CoV-2 attaches itself to these monocytes, and by doing so reverts them back to doing their original job: defending the body against cancer…
By analyzing the receptor on the monocytes that the COVID-19 virus attached to, Bharat found a compound that currently isn’t used to treat any disease but is a close mimic of the COVID-19 virus in the way that it binds to the monocyte to induce the cell’s transformation into a cancer-fighting cell…. In animal tests, the compound—called muramyl dipeptide (MDP)—reduced tumors by 60% to 70% in mice with human cancers including breast, colon, lung, and melanoma.
Full article: https://time.com/7176558/covid-19-virus-cancer-monocytes/ (approx 763 words).
And good news from Fix the News:
The EU is in the midst of finalizing a plan to completely end imports of Russian fossil fuels; the European Commission first pledged to quit Russian fossil fuels in 2022 as a response to Moscow’s invasion of Ukraine. The imports won’t completely end until 2027, but in the meantime, Czechia has achieved full independence from Russian oil for the first time in its history; the country now receives no supplies through Russia’s Druzhba pipeline, ending a 60-year dependency. This is significant because Czechia previously received half its oil from Russia and had an EU exemption from the 2022 Russian oil ban.

